Kumar Gaurav is an Audio-Visual Journalist at various esteemed publications. He specializes in finance-related themes, including cryptocurrency, global markets, and commodities, while also exploring social issues such as gender, marginalized communities, and human rights through multimedia storytelling. Kumar's work has been featured in notable outlets such as TechGraph, Financial Express (India), and The Economic Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
India (National)
Not enough data
Kumar Gaurav's coverage primarily focuses on college rankings and education, with a significant emphasis on data-driven reporting. He also covers topics related to technology, particularly blockchain, as well as finance and economy.
Given Kumar's focus on college rankings and education, he would likely be interested in pitches that provide insights into trends or changes in the Indian higher education system. This could include expert commentary from academics or educational administrators familiar with ranking methodologies or industry professionals who can speak to emerging trends in Indian higher education.
For his coverage of technology and blockchain, pitches offering expert analysis of new developments or innovations in these fields may resonate well. Additionally, for finance and economy-related topics, Kumar might appreciate pitches providing investment analysis specific to India.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Kumar Gaurav
Jindal Worldwide shares hit a 52-week high and upper circuit after subsidiary Jindal Mobilitric announced plans to expand its retail network to around 100 showrooms by FY28. The EV expansion has driven strong investor interest, with shares gaining 66.28% year-to-date.
By: Kumar Gaurav
NSE is inching closer to its much-awaited IPO as SEBI nears approval of its DRHP. While unlisted NSE shares remain 17% below their peak, BSE has corrected nearly 29% from its 52-week high. Experts compare the two exchanges on valuations, earnings, liquidity and growth prospects to assess which offers better value.
By: Kumar Gaurav
FCNR(B) deposits could boost banks' return on equity despite a mild impact on net interest margins, according to Anand Rathi. Exemptions from reserve requirements, capital-efficient lending and longer tenors could improve returns. The brokerage analysed four scenarios, including deposit costs, leverage and rising rates, to assess the scheme's benefits.
By: Kumar Gaurav
Fosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a 47% rise in Q1FY27 profit and operates globally, with strong R&D and growth.
By: Kumar Gaurav
Indian benchmark indices extended their losing streak for a fourth consecutive session on Thursday. Nifty 50 fell 0.17% and Sensex declined 0.55% amid market pressures. HDFC Bank raised nearly $12 billion through Foreign Currency Non-Resident deposits. Mahindra & Mahindra expects truck business integration by January and electric bus launch by April. Fosun Pharma is likely to divest a 5% stake in Gland Pharma through a block deal.
By: Kumar Gaurav
Ola Electric shares rose nearly 4% after the EV maker launched its first dealer-led stores across seven states. The move comes a month after opening its sales and service network to partners. Ola Electric plans to expand to more than 500 dealerships over the next couple of quarters to strengthen its retail presence.
By: Kumar Gaurav
Indian equity markets ended Friday with a relief rally, led by metal and banking stocks, as concerns over an imminent US Fed rate hike eased. Nifty gained 0.1%, while Sensex rose 0.48%. SBI Life and Tata Steel were among the top gainers, while HCL Tech and Bharti Airtel declined.
By: Kumar Gaurav
Swiggy shares rose 2.53% following block deals involving 4% equity. The company faces MSCI index removal on September 7 due to foreign ownership caps, while Q1 FY27 results showed a narrowed net loss of Rs 791 crore.
By: Kumar Gaurav
Fosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak, Axis, and ICICI Prudential Mutual Funds, while Gland Pharma shares closed higher at ₹2,932.40.
By: Kumar Gaurav
Indian equity markets experienced volatility, with the Nifty 50 extending its losing streak for four weeks. Escalating US-Iran hostilities pushed crude oil prices higher, impacting overall market sentiment. Several companies, including Tata Motors and Rail Vikas Nigam, are expected to be active on Monday. Mazagon Dock Shipbuilders and Eicher Motors also reported significant corporate developments. Lupin received US FDA approval, while JSW Steel saw production increases in August.
